Transforming Growth Factor-β1 Mechanisms in Aortic Valve Calcification: Increased Alkaline Phosphatase and Related Events

Annals of Thoracic Surgery

Volumn 83, Issue 3, 2007, Pages 946-953

  Clark Greuel, Jocelyn N ^a   Connolly, Jeanne M ^a   Sorichillo, Elizabeth ^a   Narula, Navneet R ^b   Rapoport, H Scott ^a   Mohler III, Emile R ^b   Gorman III, Joseph H ^b   Gorman, Robert C ^b   Levy, Robert J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GELATINASE A; GELATINASE B; LIPOCORTIN 5; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANIMAL CELL; AORTA STENOSIS; AORTA VALVE; AORTA VALVE DISEASE; APOPTOSIS; ARTERY CALCIFICATION; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GEL; GENE EXPRESSION; HEART SURGERY; HUMAN; HUMAN TISSUE; LEYDIG CELL; MALE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SHEEP; UPREGULATION; ZYMOGRAPHY;

ADULT; AGED; ALKALINE PHOSPHATASE; ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CALCINOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RNA; SHEEP; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33847293734     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.10.026     Document Type: Article

References (37)

1. Aronow W.S., and Kronzon I. Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients. Am J Cardiol 67 (1991) 776-777
2. Davies M.J., Treasure T., and Parker D.J. Demographic characteristics of patients undergoing aortic valve replacement for stenosis: relation to valve morphology. Heart 75 (1996) 174-178
3. Speer M.Y., and Giachelli C.M. Regulation of cardiovascular calcification. Cardiovasc Pathol 13 (2004) 63-70
4. Bostrom K., Watson K.E., Horn S., Wortham C., Herman I.M., and Demer L.L. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91 (1993) 1800-1809
5. Satta J., Melkko J., Pollanen R., et al. Progression of human aortic valve stenosis is associated with tenascin-C expression. J Am Coll Cardiol 39 (2002) 96-101
6. Jian B., Narula N., Li Q.Y., Mohler III E.R., and Levy R.J. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 75 (2003) 457-465
7. Zebboudj A.F., Imura M., and Bostrom K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 277 (2002) 4388-4394
8. Mori K., Shioi A., Jono S., Nishizawa Y., and Morii H. Expression of matrix Gla protein (MGP) in an in vitro model of vascular calcification. FEBS Lett 433 (1998) 19-22
9. O'Brien K.D., Kuusisto J., Reichenbach D.D., et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 92 (1995) 2163-2168
10. Mohler III E.R., Adam L.P., McClelland P., Graham L., and Hathaway D.R. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 17 (1997) 547-552
11. Steitz S.A., Speer M.Y., McKee M.D., et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161 (2002) 2035-2046
12. Maranto A.R., and Schoen F.J. Alkaline phosphatase activity of glutaraldehyde-treated bovine pericardium used in bioprosthetic cardiac valves. Circ Res 63 (1988) 844-848
13. Shioi A., Katagi M., Okuno Y., et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91 (2002) 9-16
14. Mohler III E.R., Gannon F., Reynolds C., Zimmerman R., Keane M.G., and Kaplan F.S. Bone formation and inflammation in cardiac valves. Circulation 103 (2001) 1522-1528
15. Hishikawa K., Nakaki T., and Fujii T. Transforming growth factor-beta(1) induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. Eur J Pharmacol 385 (1999) 287-290
16. Pollman M.J., Naumovski L., and Gibbons G.H. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99 (1999) 2019-2026
17. Mattey D.L., Dawes P.T., Nixon N.B., and Slater H. Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann Rheum Dis 56 (1997) 426-431
18. Watson K.E., Bostrom K., Ravindranath R., Lam T., Norton B., and Demer L.L. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93 (1994) 2106-2113
19. Mohler III E.R., Chawla M.K., Chang A.W., et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 8 (1999) 254-260
20. Jian B., Jones P.L., Li Q., Mohler III E.R., Schoen F.J., and Levy R.J. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol 159 (2001) 321-327
21. Jones P.L., Cowan K.N., and Rabinovitch M. Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 150 (1997) 1349-1360
22. Rodriguez-Manzaneque J.C., Lane T.F., Ortega M.A., Hynes R.O., Lawler J., and Iruela-Arispe M.L. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A 98 (2001) 12485-12490
23. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14 (2000) 163-176
24. Dallas S.L., Rosser J.L., Mundy G.R., and Bonewald L.F. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J Biol Chem 277 (2002) 21352-21360
25. Edep M.E., Shirani J., Wolf P., and Brown D.L. Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 9 (2000) 281-286
26. Soini Y., Satta J., Maatta M., and Autio-Harmainen H. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J Pathol 194 (2001) 225-231
27. Satta J., Oiva J., Salo T., et al. Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis. Ann Thorac Surg 76 (2003) 681-688
28. Simionescu A., Simionescu D., and Deac R. Biochemical pathways of tissue degeneration in bioprosthetic cardiac valves. The role of matrix metalloproteinases. ASAIO J 42 (1996) M561-M567
29. Santibanez J.F., Guerrero J., Quintanilla M., Fabra A., and Martinez J. Transforming growth factor-beta1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochem Biophys Res Commun 296 (2002) 267-273
30. Kaden J.J., Dempfle C.E., Grobholz R., et al. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis 170 (2003) 205-211
31. Kobayashi T., Hattori S., and Shinkai H. Matrix metalloproteinases-2 and -9 are secreted from human fibroblasts. Acta Derm Venereol 83 (2003) 105-107
32. Fondard O., Detaint D., Iung B., et al. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J 26 (2005) 1333-1341
33. Sullivan D.A., Sullivan B.D., Ullman M.D., et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 41 (2000) 3732-3742
34. Faziloglu Y., Stanley R.J., Moss R.H., Van Stoecker W., and McLean R.P. Colour histogram analysis for melanoma discrimination in clinical images. Skin Res Technol 9 (2003) 147-156
35. Larochelle S., Langlois C., Thibault I., Lopez-Valle C.A., Roy M., and Moulin V. Sensitivity of myofibroblasts to H2O2-mediated apoptosis and their antioxidant cell network. J Cell Physiol 200 (2004) 263-271
36. Jian B., Xu J., Connolly J., et al. Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol 161 (2002) 2111-2121
37. Kim K.M. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc 35 (1976) 156-162